Brazil Interventional Cardiology Devices Market Size & Outlook, 2025-2033
Brazil Interventional Cardiology Devices Market Insights
- Based on Reed Intelligence findings, the Brazil Interventional Cardiology Devices Market reached USD 370.64 Million in 2024 and is estimated to attain USD 722 Million by 2033.
- From 2025 to 2033, the Brazil market is expected to grow at a steady CAGR of 7.66%.
- Within the By Product Type category, Coronary Stents dominated in 2024 in terms of market size contribution.
- Over the forecast period, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons is forecasted to deliver the fastest growth, positioning it as the most lucrative By Product Type segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Brazil accounted for 2.59% of the global Interventional Cardiology Devices Market size in 2024.
- By 2033, United States is expected to remain the top global market in terms of size.
- Within LATAM, Brazil is forecasted to dominate the regional Interventional Cardiology Devices Market size by 2033.
- Brazil will be the fastest-growing market in LATAM, projected to achieve USD 720.18 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 370.64 Million |
| Market Size In 2033 | USD 722 Million |
| Largest segment | Coronary Stents |
| Units | Revenue in USD Million |
| CAGR | 7.66% (2025-2033) |
| Segmnetation Covered | |
| By Product Type |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Brazil Interventional Cardiology Devices Market By Product Type 2025-2033 (USD Million)
| By Product Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coronary Stents | XX.x | XX.x | XX.x | 140.92 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Catheters | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Other Product Types | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
